Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)
Titel:
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)
Auteur:
Lee, Elizabeth K. Tan-Wasielewski, Zhenying Aghajanian, Carol Coleman, Robert L. Curtis, Jennifer Hirsch, Michelle S. Matulonis, Ursula A. Cantley, Lewis C. Mills, Gordon B. Doyle, L. Austin Liu, Joyce F.